Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eribulin mesylate in breast cancer.
Verdaguer H, Morilla I, Urruticoechea A. Verdaguer H, et al. Among authors: urruticoechea a. Womens Health (Lond). 2013 Nov;9(6):517-26. doi: 10.2217/whe.13.61. Womens Health (Lond). 2013. PMID: 24161305 Free article.
Efficacy and safety of concurrent trastuzumab plus weekly paclitaxel-FEC as primary therapy for HER2-positive breast cancer in everyday clinical practice.
Pernas S, Gil-Gil M, de Olza MO, Gumà A, Climent F, Petit A, Pla MJ, García-Tejedor A, López-Ojeda A, Falo C, Fernandez-Otega A, Mesia C, Pérez-Martin FJ, Urruticoechea A, Germà JR. Pernas S, et al. Among authors: urruticoechea a. Breast Cancer Res Treat. 2012 Aug;134(3):1161-8. doi: 10.1007/s10549-012-2149-7. Epub 2012 Jul 8. Breast Cancer Res Treat. 2012. PMID: 22772380 Clinical Trial.
Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population.
Gómez-Miragaya J, Palafox M, Paré L, Yoldi G, Ferrer I, Vila S, Galván P, Pellegrini P, Pérez-Montoyo H, Igea A, Muñoz P, Esteller M, Nebreda AR, Urruticoechea A, Morilla I, Pernas S, Climent F, Soler-Monso MT, Petit A, Serra V, Prat A, González-Suárez E. Gómez-Miragaya J, et al. Among authors: urruticoechea a. Stem Cell Reports. 2017 May 9;8(5):1392-1407. doi: 10.1016/j.stemcr.2017.03.026. Epub 2017 Apr 27. Stem Cell Reports. 2017. PMID: 28457887 Free PMC article.
Removal of the internal mammary sentinel node in breast cancer.
Domènech-Vilardell A, Bajén MT, Benítez AM, Ricart Y, Mora J, Rodríguez-Bel L, García-Tejedor A, Climent J, López-Ojeda A, Urruticoechea A, Martín-Comín J. Domènech-Vilardell A, et al. Among authors: urruticoechea a. Nucl Med Commun. 2009 Dec;30(12):962-70. doi: 10.1097/MNM.0b013e328330addf. Nucl Med Commun. 2009. PMID: 19696690
Recent advances in cancer therapy: an overview.
Urruticoechea A, Alemany R, Balart J, Villanueva A, Viñals F, Capellá G. Urruticoechea A, et al. Curr Pharm Des. 2010 Jan;16(1):3-10. doi: 10.2174/138161210789941847. Curr Pharm Des. 2010. PMID: 20214614 Review.
Biological reprogramming in acquired resistance to endocrine therapy of breast cancer.
Aguilar H, Solé X, Bonifaci N, Serra-Musach J, Islam A, López-Bigas N, Méndez-Pertuz M, Beijersbergen RL, Lázaro C, Urruticoechea A, Pujana MA. Aguilar H, et al. Among authors: urruticoechea a. Oncogene. 2010 Nov 11;29(45):6071-83. doi: 10.1038/onc.2010.333. Epub 2010 Aug 16. Oncogene. 2010. PMID: 20711236
79 results